-
NMPA Announcement on Trial Operation of Electronic Registration Certificate for Cosmetics
2021-12-27
It has been decided upon study that electronic registration certificate for cosmetics will start trial operation since January 1, 2022. Relevant issues are hereby announced as follows.
-
NMPA CDE Announcement on Issuing the Guidance for the Preparation of Application Dossiers for TCM Theory of Compound Preparations of New Chinese Medicines (interim) and the Guidance for the Preparation of the Package Inserts of Compound Preparations of Chinese Medicines in Ancient Classic Prescriptions (interim)
2021-10-15
The CDE has organized to formulate the Guidance for the Preparation of Application Dossiers for TCM Theory of Compound Preparations of New Chinese Medicines (interim) and the Guidance for the Preparation of the Package Inserts of Compound Preparations of Chinese Medicines in Ancient Classic Prescriptions (interim).
-
NMPA CDE Announcement on Issuing the Technical Guidance for Clinical Trials of Anti-HIV Infectious Drugs
2021-10-13
The CDE has formulated the Technical Guidance for Clinical Trials of Anti-HIV Infectious Drugs, which was issued and implemented on October 12, 2021 upon the review and approval by the National Medical Products Administration.
-
NMPA CDE Announcement on Issuing the Technical Guidance for Quality Control Study of Nano Drugs (interim), Technical Guidance for Non-Clinical Pharmacokinetic Study of Nano Drugs (interim), and Technical Guidance for Non-Clinical Safety Evaluation Study of Nano Drugs (interim)
2021-08-27
The Center for Drug Evaluation has organized to formulate the Technical Guidance for Quality Control Study of Nano Drugs (interim), Technical Guidance for Non-Clinical Pharmacokinetic Study of Nano Drugs (interim), and Technical Guidance for Non-Clinical Safety Evaluation Study of Nano Drugs (interim).
-
NMPA Announcement on Issuing the Guidance for Evaluation of the Safety and Efficacy of Medical Devices Using Nano Materials-Part 1: System Framework
2021-08-26
The NMPA has organized to formulate the Guidance for Evaluation of the Safety and Efficacy of Medical Devices Using Nano Materials-Part 1: System Framework, which was issued on August 26, 2021.
-
NMPA Announcement on Issuing 2 Guidance including the Guidance for Nomenclature of the Generic Names of Neurosurgical and Cardiovascular Surgical Devices
2021-08-25
The NMPA has organized to formulate the Guidance for Nomenclature for Generic Names of Neurosurgical and Cardiovascular Surgical Devices, and Guidance for Nomenclature for Generic Names of Devices for Medical Diagnosis, Examination and Monitoring, which were issued on August 25, 2021.
